These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25931779)

  • 21. Stem-Cell Therapy for Bronchopulmonary Dysplasia (BPD) in Newborns.
    Omar SA; Abdul-Hafez A; Ibrahim S; Pillai N; Abdulmageed M; Thiruvenkataramani RP; Mohamed T; Madhukar BV; Uhal BD
    Cells; 2022 Apr; 11(8):. PubMed ID: 35455954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem Cell Therapy for Neonatal Disorders: Prospects and Challenges.
    Chang YS; Ahn SY; Sung S; Park WS
    Yonsei Med J; 2017 Mar; 58(2):266-271. PubMed ID: 28120555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in bronchopulmonary dysplasia.
    Strueby L; Thébaud B
    Expert Rev Respir Med; 2014 Jun; 8(3):327-38. PubMed ID: 24666156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in treating bronchopulmonary dysplasia.
    Williams E; Greenough A
    Expert Rev Respir Med; 2019 Aug; 13(8):727-735. PubMed ID: 31244360
    [No Abstract]   [Full Text] [Related]  

  • 25. How to introduce MSC-based therapy for the developing lung safely into clinical care?
    Rüdiger M; Kirpalani H; Steinhorn R; Davis JM; Thebaud B
    Pediatr Res; 2020 Sep; 88(3):365-368. PubMed ID: 31931507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal Stromal Cell Therapy for Respiratory Complications of Extreme Prematurity.
    Thébaud B
    Am J Perinatol; 2018 May; 35(6):566-569. PubMed ID: 29694998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-based strategies to reconstitute vital functions in preterm infants with organ failure.
    Bohlin K
    Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():99-111. PubMed ID: 26527306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-based strategies to reconstitute lung function in infants with severe bronchopulmonary dysplasia.
    O'Reilly M; Thébaud B
    Clin Perinatol; 2012 Sep; 39(3):703-25. PubMed ID: 22954277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchopulmonary Dysplasia: 50 Years after the Original Description.
    Bancalari E; Jain D
    Neonatology; 2019; 115(4):384-391. PubMed ID: 30974430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel therapeutics for bronchopulmonary dysplasia.
    Strueby L; Thébaud B
    Curr Opin Pediatr; 2018 Jun; 30(3):378-383. PubMed ID: 29465463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human amnion cells for the prevention of bronchopulmonary dysplasia: a protocol for a phase I dose escalation study.
    Baker EK; Malhotra A; Lim R; Jacobs SE; Hooper SB; Davis PG; Wallace EM
    BMJ Open; 2019 Mar; 9(2):e026265. PubMed ID: 30826799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal stem cell therapy for intractable neonatal disorders.
    Ahn SY; Park WS; Sung SI; Chang YS
    Pediatr Neonatol; 2021 Feb; 62 Suppl 1():S16-S21. PubMed ID: 33485822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal Stem Cells: The Magic Cure for Intraventricular Hemorrhage?
    Park WS; Ahn SY; Sung SI; Ahn JY; Chang YS
    Cell Transplant; 2017 Mar; 26(3):439-448. PubMed ID: 27938484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis of Preclinical Studies.
    Augustine S; Avey MT; Harrison B; Locke T; Ghannad M; Moher D; Thébaud B
    Stem Cells Transl Med; 2017 Dec; 6(12):2079-2093. PubMed ID: 29045045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem Cells for Neonatal Brain Disorders.
    Ahn SY; Chang YS; Park WS
    Neonatology; 2016; 109(4):377-83. PubMed ID: 27251746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchopulmonary Dysplasia: Where Have All the Stem Cells Gone?: Origin and (Potential) Function of Resident Lung Stem Cells.
    Möbius MA; Thébaud B
    Chest; 2017 Nov; 152(5):1043-1052. PubMed ID: 28479114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell therapy: a novel treatment approach for bronchopulmonary dysplasia.
    Vosdoganes P; Lim R; Moss TJ; Wallace EM
    Pediatrics; 2012 Oct; 130(4):727-37. PubMed ID: 22945412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth factors, stem cells and bronchopulmonary dysplasia.
    Alphonse RS; Thébaud B
    Neonatology; 2011; 99(4):326-37. PubMed ID: 21701205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in understanding and management of bronchopulmonary dysplasia.
    Sahni M; Bhandari V
    F1000Res; 2020; 9():. PubMed ID: 32704351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.